{"id":1014,"date":"2019-09-11T12:42:10","date_gmt":"2019-09-11T11:42:10","guid":{"rendered":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/?p=1014"},"modified":"2019-09-11T12:42:10","modified_gmt":"2019-09-11T11:42:10","slug":"mrc-board-and-panel-vacancies-from-april-2020","status":"publish","type":"post","link":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/2019\/09\/11\/mrc-board-and-panel-vacancies-from-april-2020\/","title":{"rendered":"MRC Board and Panel Vacancies from April 2020"},"content":{"rendered":"<p><strong>Apply by 30th September 2019, 4pm<\/strong><\/p>\n<p>MRC Board and Panel Vacancies from April 2020<br \/>\n<a href=\"https:\/\/mrc.ukri.org\/about\/our-structure\/research-boards-panels\/mrc-board-panel-vacancies\/\">https:\/\/mrc.ukri.org\/about\/our-structure\/research-boards-panels\/mrc-board-panel-vacancies\/<\/a><br \/>\nonline application form:<br \/>\n<a href=\"https:\/\/mrc.ukri.org\/about\/our-structure\/research-boards-panels\/mrc-board-panel-vacancies\/apply-for-a-board-or-panel-vacancy\/\">https:\/\/mrc.ukri.org\/about\/our-structure\/research-boards-panels\/mrc-board-panel-vacancies\/apply-for-a-board-or-panel-vacancy\/<\/a><\/p>\n<p>MRC seeks to fill up to 28 vacancies across 4 Research Boards and 22 vacancies in 5 of their 6 Panels<\/p>\n<p>Please note, Applicants must have both permission and support from their host institution before applying<\/p>\n<p>Personal specification includes:<br \/>\n\u2022 ask that applicants have a sound knowledge of experimental design and statistical approaches to ensure the highest standards of methodological rigor<br \/>\n\u2022 a first class record in conducting and leading internationally respected research<br \/>\n\u2022 a successful track record in applying for and obtaining major grant funding over a number of years<br \/>\n\u2022 a proven ability to exercise judgment across a broad spectrum of research and policy issues with a vision of the priorities and opportunities, not only within his\/her areas of expertise, but also across the research board or panel portfolio<\/p>\n<p>Aim to:<br \/>\n\u2022 steadily increase the number of women (from the current 42% towards 50%)<br \/>\n\u2022 broaden the diversity of members<br \/>\n\u2022 increase the ratio of mid-career to later-career members<br \/>\n\u2022 ensure a strong representation for basic research and data sciences<br \/>\n\u2022 have industry representation.<\/p>\n<p>As part of the preparation for their tenure, all new board and panel members are expected to attend an induction meeting on Thursday 6 February 2020 at BEIS Conference Centre, 1 Victoria St, Westminster, London SW1H 0ET. Please hold this date when making an application.<\/p>\n<p>Research Board vacancies<\/p>\n<p>Infections &amp; immunity Board (IIB)<br \/>\n9 vacancies:<br \/>\nThe board has particular interest in extending its global health activities, addressing the challenge of antimicrobial resistance, strengthening pandemic preparedness, investigating immunity and infection through the life course, and supporting integrative data analysis and systems approaches.<\/p>\n<p>\u2022 Bacteriology \/ microbiology &#8211; with expertise in physiology, pathogenesis or virulence mechanisms.<br \/>\n\u2022 Cellular immunology &#8211; with expertise in T cells, dendritic cells, macrophage biology or immunotherapy.<br \/>\n\u2022 Computational modelling and analysis, and\/or use of artificial intelligence &#8211; in systems approaches to infections and immunity and\/or the development of diagnostics or advanced therapeutics<br \/>\n\u2022 Global health &#8211; with special interest in vector borne disease, parasitology or tropical infections and experience of working in a Low and Middle-Income Country<br \/>\n\u2022 Immune homeostasis &#8211; with expertise in one or more of the following areas: regulatory immune mechanisms, microbiome-immune interactions, immune- mediated inflammatory diseases.<br \/>\n\u2022 Virology and viral diseases &#8211; with a focus on physiology, pathogenesis or virus-host interactions.<br \/>\n\u2022 Vaccinology &#8211; with expertise in adjuvants, and\/or vaccine development.<\/p>\n<p>MRC are particularly interested to hear from applicants who have expertise in molecular biology, biochemistry, structural biology, global health, experimental medicine, data science, drug discovery, clinical trials or translational research of relevance to the Board\u2019s activities. They strongly welcome applications from candidates from the clinical and the industrial sector.<\/p>\n<p>Molecular &amp; Cellular Medicine Board (MCMB)<br \/>\n6 vacancies:<br \/>\nThe board has particular interest in understanding dynamic biological systems across scales, the link between external exposures and causal pathways of disease, and radiation oncology and biology<\/p>\n<p>Applications are invited from clinical and non-clinical scientists.<\/p>\n<p>\u2022 Mammalian developmental genetics &#8211; core expertise in the use of mammalian model systems to explore the genetics and biology of development, ideally including embryology. Broader expertise in transgenics, gene function\/regulation, cell biology and signaling, and non-mammalian model systems would be desirable.<br \/>\n\u2022 Genomic instability and repair &#8211; with core expertise in genome stability, DNA repair and DNA damage signaling. Broad knowledge relevant to cell biology including biology of the nucleus would be desirable.<br \/>\n\u2022 Structural biology &#8211; core expertise in a broad range of biophysical methods and integrated structural studies approaches; expertise in NMR would be desirable. The appointee should have a track record in structure-function studies. Knowledge of signal transduction, cell biology and structure-based drug discovery would be desirable.<br \/>\n\u2022 Industry representative &#8211; currently employed within, or strong experience of, the biomedical research industry sector. Knowledge in areas including cell signaling, functional genomics, stratified medicine, target validation\/drug development or advanced therapies would be desirable<br \/>\n\u2022 Up to two vacancies covering:<br \/>\no Medical oncology (with preference for clinically qualified\/active biomedical researchers)<br \/>\no Cancer genetics &#8211; with broad expertise in the molecular biology of cancer, particularly in areas of cancer cell adhesion\/migration, cell cycle control, mechanisms of invasion\/metastasis, cellular signaling, and cancer gene predisposition\/function\/regulation. Experience of experimental medicine, translational cancer studies and an awareness of cancer in a global health context would be desirable.<\/p>\n<p>MRC are particularly interested to receive applications from those with expertise in the use of quantitative analytical tools, and\/or multi-dimensional data and systems approaches applied to resolving complex biological problems across scale, space and time.<\/p>\n<p>Neurosciences &amp; Mental Health Board (NMHB)<br \/>\n6 vacancies:<br \/>\nThe board has a particular interest in addressing the challenges of mental illness and neurodegenerative diseases as well as exploring what we can learn from the direct study of human brain tissue to gain insight into the function of the human brain.<\/p>\n<p>Applications are invited from clinical and non-clinical scientists.<\/p>\n<p>\u2022 Cellular and molecular neurobiology \u2013 with expertise in neurodegeneration, synaptic plasticity or behavioural neuroscience.<br \/>\n\u2022 Neurodegeneration \u2013 with expertise in neuroinflammation and\/or translational research.<br \/>\n\u2022 Mental health \u2013 with expertise in one or more of the areas of : genetics, genomics, clinical psychiatry, experimental medicine and translational approaches.<br \/>\n\u2022 Neuro-repair\/regeneration \u2013 with expertise in clinical neurology.<br \/>\n\u2022 Addiction \u2013 with expertise in clinical neurology, clinical psychiatry, drug metabolism.<\/p>\n<p>MRC are particularly interested to hear from applicants who have expertise in clinical genetics, modelling approaches, and translational neuroscience. Knowledge of a range of neuroimaging and non-invasive biophysical techniques will be an advantage.<\/p>\n<p>Population &amp; Systems Medicine Board (PSMB)<br \/>\n7 vacancies:<br \/>\nThe board has particular interest in understanding multimorbidity and disease clustering, mechanisms of rare diseases to provide insight into more common conditions, and integrated population health with a special emphasis on data integration.<\/p>\n<p>\u2022 Clinical cardiology and cardiovascular medicine \u2013 with expertise in genetics of cardiovascular disease. Knowledge of imaging techniques, including clinical imaging, would be desirable.<br \/>\n\u2022 Musculoskeletal research (two vacancies) &#8211; with expertise in muscle, bone and\/or cartilage physiology and pathogenesis of osteoarthritis. Broad interest in and knowledge of ageing research (beyond musculoskeletal ageing), resilience and frailty would be desirable.<br \/>\n\u2022 Renal medicine \u2013 with expertise in mechanisms of disease.<br \/>\n\u2022 Inflammation \u2013 with expertise in resolution of inflammation and cellular mechanisms of inflammatory disease.<br \/>\n\u2022 Epidemiology and population health sciences \u2013 with expertise and\/or keen interest in enhancing classical epidemiological methods with new approaches to complex\/distributed data collection and analysis. A strong background in experimental design would be advantageous.<br \/>\n\u2022 Functional genomics \u2013 with expertise in large scale genomics and epigenomics. Knowledge of functional metagenomics linked to the role of the human microbiome in chronic conditions (e.g. inflammatory bowel disease, obesity, liver disease and female reproductive system disorders) would be desirable.<\/p>\n<p>MRC are particularly interested to hear from applicants who take multi-modal approaches and integrate and interrogate complex multidimensional data e.g. combining population genomics with cell biology and capitalising on the rich molecular and phenotypic data sets from human and experimental systems. Applicants with expertise in machine learning and computational models that can be evaluated experimentally are strongly encouraged to apply.<\/p>\n<p>Funding Panel vacancies<\/p>\n<p>Developmental Pathway Funding Scheme Panel (DPFS)<br \/>\n8 vacancies:<\/p>\n<p>\u2022 Diagnostic development and implementation<br \/>\n\u2022 Medicinal chemistry<br \/>\n\u2022 Cardiovascular medicine<br \/>\n\u2022 Oncology<br \/>\n\u2022 Advanced therapies, including antibodies, peptides and cell &amp; gene therapies<br \/>\n\u2022 Molecular pharmacology, including pre-clinical toxicology<br \/>\n\u2022 Statistics, including early phase clinical trial and pre-clinical<br \/>\n\u2022 Infectious diseases and global health<\/p>\n<p>Applications from clinically active researchers, researchers based in industry and those with knowledge of the relevant investment landscape would be particularly welcomed. Given the breadth of applications received by the scheme, panel members are required to cover a broad portfolio and individual applicants would ideally be able to cover multiple areas.<\/p>\n<p>MRC-NIHR Methodology Research Programme Panel (MRP)<br \/>\n5 vacancies:<\/p>\n<p>MRC seeks applications from experienced researchers with a broad scientific, and a very strong methodological background. To ensure regional and sectoral representation, researchers based outside of London or from industry are particularly encouraged.<\/p>\n<p>\u2022 Clinical Informatics; health systems, services and delivery; computer- or data-science skills for health<br \/>\n\u2022 Causal modelling and inference; observational studies; triangulation<br \/>\n\u2022 Biostatistics; genetic epidemiology; computational statistics; meta-analytical models<br \/>\n\u2022 Co-membership with PSMB (see Board vacancies)<br \/>\n\u2022 Co-membership with MCMB (see Board vacancies).<\/p>\n<p>Co-membership ensures that advances and challenges from research methodology are embedded across MRC funding decisions and strategy. Where appropriate, applicants applying to the vacancies within other Boards and Panels should indicate their availability for dual membership with MRP.<\/p>\n<p>Training and Career Development Panels<\/p>\n<p>Non-Clinical Training and Career Development Panel<br \/>\nUp to 5 vacancies.<\/p>\n<p>Panel members contribute to assessments and interviews across the full range of MRC\u2019s work, and this year they would particularly welcome applications from researchers who would bring core expertise in:<\/p>\n<p>\u2022 Cell biology and cancer\/ cell and structural biology<br \/>\n\u2022 Population scale biomedical research \/ genetic epidemiology<br \/>\n\u2022 Public health and prevention<br \/>\n\u2022 Imaging \/ microscopy technology or applications<\/p>\n<p>Candidates with clinical expertise would be particularly welcome.<\/p>\n<p>Clinical Training and Career Development Panel<br \/>\nUp to 4 vacancies.<\/p>\n<p>Panel members contribute to assessments and interviews across the full range of MRC\u2019s work, and this year MRC would particularly welcome applications from researchers who would bring core expertise in:<\/p>\n<p>\u2022 Endocrinology and metabolic medicine<br \/>\n\u2022 Stem cell biology<br \/>\n\u2022 Oncology<br \/>\n\u2022 Data science and artificial intelligence<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Apply by 30th September 2019, 4pm MRC Board and Panel Vacancies from April 2020 https:\/\/mrc.ukri.org\/about\/our-structure\/research-boards-panels\/mrc-board-panel-vacancies\/ online application form: https:\/\/mrc.ukri.org\/about\/our-structure\/research-boards-panels\/mrc-board-panel-vacancies\/apply-for-a-board-or-panel-vacancy\/ MRC seeks to fill up to 28 vacancies across 4 Research Boards and 22 vacancies in 5 of their 6 Panels &hellip; <a href=\"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/2019\/09\/11\/mrc-board-and-panel-vacancies-from-april-2020\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":8194,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-1014","post","type-post","status-publish","format-standard","hentry","category-events"],"_links":{"self":[{"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/posts\/1014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/users\/8194"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/comments?post=1014"}],"version-history":[{"count":1,"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/posts\/1014\/revisions"}],"predecessor-version":[{"id":1015,"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/posts\/1014\/revisions\/1015"}],"wp:attachment":[{"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/media?parent=1014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/categories?post=1014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.ncl.ac.uk\/icmresearchfunding\/wp-json\/wp\/v2\/tags?post=1014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}